Changes in hyaluronan production and metabolism following ischaemic stroke in man

Brain

Volumn 129, Issue 8, 2006, Pages 2158-2176

  Al'Qteishat, Ahmed ^a   Gaffney, John ^a   Krupinski, Jerzy ^d,e   Rubio, Francisco ^d,e   West, David ^c   Kumar, Shant ^b   Kumar, Patricia ^a   Mitsios, Nicholas ^a   Slevin, Mark ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

Hyaluronan; Hyaluronan synthase; Hyaluronidase; Ischaemic stroke; RHAMM

Indexed keywords

BINDING PROTEIN; DISACCHARIDE; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIDASE; TUMOR NECROSIS FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; AUTOPSY; BIOTINYLATION; BLOOD VESSEL; BRAIN INFARCTION; BRAIN REGION; CELL INFILTRATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MOLECULAR WEIGHT; MONONUCLEAR CELL; NERVE CELL; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SYNTHESIS; TUNICA MEDIA; UPREGULATION; WESTERN BLOTTING;

EID: 33745880779     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awl139     Document Type: Article

References (58)

1. Adamia S, Maxwell CA, Pilarski LM. Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Curr Drug Targets Cardiovasc Haematol Disord 2005; 5: 3-14.
2. + exchanger (NHEI) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumour cell invasion. J Biol Chem 2004; 278: 26991-7007.
3. Bruckner G, Szeoke S, Pavlica S, Grosche J, Kacza J. Axon initial segment ensheathed by extracellular matrix perineuronal nets. Neuroscience 2006; 138: 365-75.
4. Carulli D, Rhodes KE, Brown DJ, Bonnert TP, Pollack SJ, Oliver K, et al. Composition of perineuronal nets in the adult rat cerebellum and the cellular origin of their components. J Comp Neurol 2006; 494: 559-77.
5. Castensson A, Emilsson L, Preece P, Jazin EE. High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies. Genome Res 2000; 10: 1219-29.
6. Coyle P, Heistad D. Blood flow through cerebral collateral vessels one month after middle cerebral artery occlusion. Stroke 1987; 18: 407-11.
7. Delpech B, Delpech A, Bruckner G, Girard N, Maingonnat C. Hyaluronan and hyaluronectin in the nervous system. Ciba Found Symp 1989; 143: 208-20.
8. Hascall VC, Majors AK, de la Motte CA, Evanko SB, Wang A, Drazba JA, et al. Intracellular hyaluronan: a new frontier for inflammation. Biochim Biophys Acta 2004; 1673: 3-12.
9. Hou S, Tian W, Xu Q, Cui F, Zhang J, Lu Q, et al. The enhancement of cell adherence and inducement of neurite outgrowth of dorsal root ganglia co-cultured with hyaluronic acid hydrogels modified with Nogo-66 receptor antagonist in vitro. Neuroscience 2006; 137: 519-29.
10. Issa R, AlQteishat A, Mitsios N, Saka M, Krupinski J, Tarkowski E, et al. Expression of basic fibroblast growth factor mRNA and protein in the human brain following ischaemic stroke. Angiogenesis 2005; 8: 53-62.
11. Itano N, Kimata K. Mammalian hyaluronan synthases. Life 2002; 54: 195-9.
12. Jonas B, Paraskevi H. Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44. Exp Cell Res 1999; 252: 342-51.
13. Krupinski J, Kaluza J, Kumar P, Wang M, Kumar S. Prognostic value of blood vessel density in ischaemic stroke. Lancet 1993; 341: 925-7.
14. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. Role of angiogenesis in patients with ischaemic cerebral stroke. Stroke 1994; 25: 1794-8.
15. Krupinski J, Kumar P, Kumar S, Kaluza J. Increased expression of TGF-β1 in brain tissue after ischaemic stoke in humans. Stroke 1996; 27: 852-7.
16. Krupinski J, Issa R, Bujny T, Slevin M, Kumar P, Kumar S, et al. A putative role for platelet derived growth factor in angiogenesis and neuroprotection after ischaemic stroke in humans. Stroke 1997; 28: 564-73.
17. Krupinski J, Lopez E, Marti E, Ferrer F. Expression of caspases and their substrates in the rat model of focal cerebral ischaemia. Neurobiol Dis 2000; 7: 332-42.
18. Krupinski J, Stroemer P, Slevin M, Marti E, Kumar P, Rubio F. Three-dimensional structure of newly formed blood vessels after focal cerebral ischaemia in rat. Neuroreport 2003; 14: 1171-6.
19. Laurent UB, Laurent TC, Hellsing LK, Persson L, Hartman M, Lilja K. Hyaluronan in human cerebrospinal fluid. Acta Neurol Scand 1996 Sep; 94:194-206.
20. Lepperdinger G, Muellegger J, Kreill G. Hyal-2, less active but more versatile. Matrix Biol 2001; 20: 509-14.
21. Lesley J, English NM, GaI I, Kikecz K, Day AJ, Hyman R. Hyaluronan binding properties of a CD44 chimera containing the link module of TSG-6. J Biol Chem 2002; 277: 26600-8.
22. Lesley J, Gal I, Mahoney DJ, Cordell MR, Rugg MS, Hyman R, et al. TSG-6 modulates the interaction between hyaluronan and cell surface CD44. J Biol Chem 2004; 279: 25745-54.
23. Lipton P. Ischaemic cell death in brain neurons. Physiol Rev 1999; 79: 431-68.
24. Love S. Apoptosis and brain ischaemia. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 267-82.
25. Lynn BD, Turley EA, Nagy JI. Subcellular distribution, calmodulin interaction, and mitochondrial association of the hyaluronan-binding protein RHAMM in rat brain. J Neurosci Res 2001; 65: 6-16.
26. Mahoney DJ, Mulloy B, Forster MJ, Blundell CD, Fries E, Milner CM, et al. Characterization of the interaction between tumour necrosis factor-stimulated gene-6 and heparin: implications for the inhibition of plasmin in extracellular matrix microenvironments. J Biol Chem 2005; 280: 27044-55.
27. Milner CM, Day AJ. TSG-6 a multifunctional protein associated with inflammation. J Cell Sci 2003; 116: 1863-73.
28. Mio K, Carrette O, Maibach HI, Stern R. Evidence that the serum inhibitor of hyaluronidase may be a member of the inter-α-inhibitor family. J Biol Chem 2000; 275: 13-21.
29. Mitsios N, Gaffney J, Kumar P, Kumar S, Slevin M. Apoptosis after ischaemic stroke. Cell Biochem Biophys 2006. In press.
30. Nagy JI, Hacking J, Frankenstein UN, Turley EA. Requirement of the Hyaluronan receptor RHAMM in neurite extension and motility as demonstrated in primary neurons and neuronal cell lines. J Neurosci 1995; 15: 241-52.
31. Natowicz MR, Wang Y. Human serum hyaluronidase: characterisation of a clinical assay. Clin Chim Acta 1996; 245: 1-6.
32. Noble PW. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 2002; 21: 25-9.
33. Novak SS, Stylii AH, Kaye AH, Lepperdinger G. Hyaluronidase-2 overexpression accelerates intracerebral but not subcutaneous tumor formation of murine astrocytoma cells. Cancer Res 1999; 59: 6246-50.
34. Prehm P. Hyaluronan is synthesized at plasma membranes. Biochem J 1984; 220: 597-600.
35. Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med 2001; 7: 213-21.
36. Rauch U. Extracellular matrix components associated with remodelling processes in brain. Cell Mol Life Sci 2004; 61: 2031-45.
37. Ripellino JA, Bailo M, Margiolis RU, Margolis RK. Light and electron microscopic studies on the localization of hyaluronic acid in developing rat cerebellum. J Cell Biol 1988; 106: 845-55.
38. Rubio F, Martinez-Yelamos S, Cardona P, Krupinski J. Carotidendarterectomy: is it still the gold standard? Cerebrovasc Dis 2005; 20: 119-22.
39. Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, DeLisser HM. Differential involvement of the receptor of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 2001; 276: 36770-8.
40. Sbarbarti A, Pietra C, Baldassari AM, Guerrini U, Ziviani L, Reggiani A, et al. The microvascular system in ischaemic cortical lesions. Acta Neuropathol (Berlin) 1996; 92: 56-63.
41. Scandinavian Stroke Study Group (1985), Multicentre trial of hemodilution in ischaemic stroke: background and study protocol. Stroke 1985; 16: 885-90.
42. Sherman LS, Struve JN, Rangwala R, Wallingford NM, Tuohy MF, Kuntz C IV. Hyaluronate-based extracellular matrix: keeping glia in their place. Glia 2002; 38: 93-102.
43. Shuttleworth TL, Wilson MD, Wicklow BA, Wilkins JA, Triggs-Raine BL. Characterization of the murine hyaluronidase gene region reveals complex organization and cotranscription of HYAL1 with down-stream genes Fus2 and HYAL3. J Biol Chem 2002; 277: 23008-18.
44. Slevin M, Krupinski J, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest 1998; 78: 987-1003.
45. Slevin M, Krupinski J, Slowik A, Kumar P, Szczudlik A, Gaffney J. Serial measurement of vascular endothelial growth factor and transforming growth factor beta1 in serum of patients with acute ischaemic stroke. Stroke 2000; 31: 1863-70.
46. Slevin M, Kumar S, Gaffney J. Angiogenic ologosaccharides of hyaluronan induce multiple signal transduction pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 2002; 277: 41046-59.
47. Slevin M, West D, Kumar S. Hyaluronan, angiogenesis and malignant disease. Int J Cancer 2004; 109: 793-4.
48. Slevin M, Krupinski J, Kumar P, Gaffney J, Kumar S. Gene activation and protein expression following ischaemic stroke: strategies towards neuroprotection. J Cell Mol Med 2005; 9: 85-102.
49. Stern R. Devising a pathway for hyaluronate catabolism: are we there yet? Glycobiology 2003; 12: 105R-15R.
50. Struve J, Maher PC, Li YQ, Kinney S, Fehlings MG, Kuntz C IV, et al. Disruption of the hyaluronan-based extracellular matrix in spinal cord promotes astrocyte proliferation. 2005; 52: 16-24.
51. Tammi MI, Day AJ, Turley EA. Hyaluronan and homeostasis: a balancing act. J Biol Chem 2002; 277: 4581-4.
52. Usui T, Amano S, Oshika T, Suzuki K, Miyata K, Arai M, et al. Expression regulation of hyaluronan synthase in corneal endothelial cells. Invest Ophthalmol Vis Sci 2000; 41: 3261-7.
53. Wang KK, Nemeth IR, Seckel BR, Chakalis-Haley DP, Swann DA, Kuo JW, et al. Hyaluronic acid enhances peripheral nerve regeneration in vivo. Microsurgery 1998; 18: 270-5.
54. Wang X, Xu L, Wang H, Zhan Y, Pure E, Feuerstein GZ. CD44 deficiency in mice protects brain from cerebral ischemia injury. J Neurochem 2002; 83: 1172-9.
55. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985; 228: 1324-6.
56. West DC, Kumar S. The effect of hyaluronan and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 1989; 183: 179-86.
57. West DC, Lees VC, Fan TP. Angiogenesis in a delayed revascularisationmodel is accelerated by oligosaccharides of hyaluronan. Lab Invest 1995; 73: 259-66.
58. Yasahara O, Akiyama H, McGeer EG, McGeer PL. Immunohistochemical localisation of hyaluronic acid in rat and human brain. Brain Res 1994; 28: 269-82.